Sarah Butler

Sarah Butler is the head of Sales, Marketing, and Operations.

She specializes in evidence-based medicine, value-based contracting, and strategy development. Sarah is a frequent speaker about healthcare trends and is an industry expert on value-based contracting.

Prior to joining Avalere, Sarah held positions at the Cato Institute, the Brookings Institution, McGuireWoods LLP, and Goodell, DeVries, Leech & Dann LLP.

Sarah has an MHS in Health Policy from the Johns Hopkins University Bloomberg School of Public Health and a BA in History from the University of Richmond.

Authored Content

Join Avalere experts as they take a closer look at emerging oncology trends, innovative approaches to payment and delivery, and what these changes will mean for patient access.

Join Avalere experts for Part 1 of our Market Access Enablement Strategies webinar series to learn about how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.

Join Avalere experts for Part 2 of our Market Access Enablement Strategies webinar series to learn about the policy changes and market factors that could impact the future relationships between manufacturers, health plans, and pharmacy benefit managers.

Avalere experts examined evolving stakeholder-specific considerations for reshaping how patients with autoimmune conditions receive care during and after the COVID-19 pandemic.

View the webinar recording to learn more about the latest policy, pricing, and reimbursement challenges in Medicaid.

Cost savings and improved clinical outcomes cited as top advantages for payers according to survey conducted by Avalere Health.

On January 10, Avalere experts examined the top healthcare priorities to watch in 2019.

Avalere experts expand on significant priorities for 2018.

Avalere experts examine the challenges and successful approaches to outcomes-based contracts.

Avalere experts say use of outcomes-based contracts could further goals to improve patient outcomes and manage drug costs

Hepatitis C and Oncology Are Top Therapeutic Area Targets

Welcome to our first issue of Avalere Health Quarterly, a sector-by-sector analysis of major issues and moving parts in healthcare for the coming 3 to 6 months. The Quarterly offers Avalere expert opinion on how major industry catalysts will impact your business decisions.